Table 4: Adverse effects regarding
sedation protocol.
|
|
TCI (n=27) |
Bolus (n=27) |
Total (n=54) |
p-value |
|
HR
> 125 bpm |
2
(7%) |
10
(37%) |
12
(22%) |
0.009 |
|
HR < 50 bpm |
0
(0%) |
1
(4%) |
1(2%) |
0.313 |
|
RRsys
<90 mmHg |
10
(37%) |
2
(7%) |
12
(22%) |
0.080 |
|
RRsys <80 % of bl |
17
(63%) |
14
(52%) |
31
(57%) |
0.802 |
|
RRsys
>120 % of bl |
8
(30%) |
15
(56%) |
23
(43%) |
0.070 |
|
SpO2 <90 % >10s |
18
(69%) |
18
(67%) |
36
(68%) |
ns |
|
SpO2
<80 % >10s |
4
(15%) |
5
(19%) |
9 (17%) |
ns |
|
Resp. rate <8/min |
16
(59%) |
16
(59%) |
32
(59%) |
ns |
Expressed as number (n) and percentage
(%).
TCI:
Target-Controlled Infusion; HR: Heart Rate; BPM: Beats Per Minute; NS: Not
Specified; BL: Baseline.